Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain
  • Study of Apitegromab Treatment in Children Under 2 Years Old with Spinal Muscular Atrophy (SMA)

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain
  • Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy The Netherlands +1
  • Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

    Recruiting

    2 1 1
    France
  • Study of inhaled corticosteroids (beclometasone, fluticasone, budesonide) and salbutamol in children aged 1-6 years with episodic wheezing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Comparing brincidofovir and cidofovir for treating adenovirus infection in children and adults after stem cell transplantation

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Portugal Spain
  • Study of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures

    Recruiting

    3 1 1
    Investigated Diseases:
    Germany Italy
  • Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

    Recruiting

    3 1
    Czechia France Italy Poland Spain
  • Study of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Greece Italy Spain Sweden